Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
出版年份 2023 全文链接
标题
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
作者
关键词
-
出版物
Journal of Translational Medicine
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-06
DOI
10.1186/s12967-023-04673-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study
- (2023) Xi Ding et al. JOURNAL OF CLINICAL ONCOLOGY
- Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations
- (2023) Diana Mandelker et al. npj Precision Oncology
- Application of Artificial Intelligence to the Diagnosis and Therapy of Nasopharyngeal Carcinoma
- (2023) Xinggang Yang et al. Journal of Clinical Medicine
- Patients' perspectives related to ethical issues and risks in precision medicine: a systematic review
- (2023) Lawko Ahmed et al. Frontiers in Medicine
- Clinicopathological analysis and prognostic significance of NF-κB p65 and IKKβ protein and mRNA expression in nasopharyngeal carcinoma
- (2022) Mei Zhou et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- MRI detection of suspected nasopharyngeal carcinoma: a systematic review and meta-analysis
- (2022) Vineet Vijay Gorolay et al. NEURORADIOLOGY
- Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
- (2022) Patrick Schöffski et al. Journal for ImmunoTherapy of Cancer
- Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives
- (2022) Zhi Yi Su et al. Frontiers in Oncology
- Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
- (2022) P. Osterlund et al. ESMO Open
- Ethical Considerations in Precision Medicine and Genetic Testing in Internal Medicine Practice: A Position Paper From the American College of Physicians
- (2022) Lisa Soleymani Lehmann et al. ANNALS OF INTERNAL MEDICINE
- New synthetic phenylquinazoline derivatives induce apoptosis by targeting the pro-survival members of the BCL-2 family
- (2022) Samson Eugin Simon et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- STAT3 activation as a predictive biomarker for ruxolitinib response in head and neck cancer
- (2022) Zoya Qureshy et al. CLINICAL CANCER RESEARCH
- The prognostic significance of β-Catenin expression in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis
- (2022) Liu-Qing Zhou et al. Frontiers in Genetics
- DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway
- (2022) Shirong Ding et al. EBioMedicine
- Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches
- (2022) Katarzyna A. Roszkowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication
- (2022) Ruo-Wen Xiao et al. EBioMedicine
- Role of STAT3 in the pathogenesis of nasopharyngeal carcinoma and its significance in anticancer therapy
- (2022) Yishimei Si et al. Frontiers in Oncology
- Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy
- (2022) Ee Wern Tan et al. Pathogens
- Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
- (2022) A.T.C. Chan et al. ANNALS OF ONCOLOGY
- Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
- (2021) Feng-Hua Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- LncRNA TP73‐AS1 regulates miR ‐495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A
- (2021) Bao‐Qiang Dai et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma
- (2021) David Johnson et al. ORAL ONCOLOGY
- The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
- (2021) Angela Kwok-Fung Lo et al. Frontiers in Oncology
- The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies
- (2021) Merrin Man Long Leong et al. Frontiers in Oncology
- Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetcs/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer
- (2021) Carlos Gomez‐Roca et al. CTS-Clinical and Translational Science
- PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
- (2021) Rosalin Mishra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Human Caspase 12 Enhances NF-κB Activity through Activation of IKK in Nasopharyngeal Carcinoma Cells
- (2021) Shu-Er Chow et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
- (2021) Corey Smith et al. npj Precision Oncology
- Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients
- (2021) Mengqi Zhuang et al. Aging-US
- Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, Versus Chemotherapy in Patients With Recurrent/Metastatic Nasopharyngeal Cancer
- (2021) Caroline Even et al. CLINICAL CANCER RESEARCH
- JUPITER-02: Randomized, double-blind, phase III study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC).
- (2021) Rui-hua Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer
- (2021) Ramon Yarza et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Yunpeng Yang et al. LANCET ONCOLOGY
- The tangled history of mRNA vaccines
- (2021) Elie Dolgin NATURE
- Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
- (2021) Hai-Qiang Mai et al. NATURE MEDICINE
- Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects
- (2021) Ying Gao et al. World Journal of Surgical Oncology
- Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics
- (2021) Ren-Bo Ding et al. Nature Communications
- Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape
- (2021) Jeff P. Bruce et al. Nature Communications
- Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma
- (2021) Pui Yan Siak et al. Cancers
- A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
- (2021) Peter Shaw et al. Cancers
- Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy
- (2021) Xingzhe Li et al. JAMA Network Open
- Precision medicine: Concept and tools
- (2021) Nardeep Naithani et al. Medical Journal Armed Forces India
- Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
- (2021) Matthew H. Taylor et al. CLINICAL CANCER RESEARCH
- Retraction Note: MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by downregulating LHX2
- (2021) Tian-Song Liang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
- (2021) Farzaneh Kordbacheh et al. Cancers
- Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal cancer
- (2020) Jin Zhao et al. CANCER LETTERS
- Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?
- (2020) Liam Masterson et al. INTERNATIONAL JOURNAL OF CANCER
- Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting
- (2020) Chaosheng Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma
- (2020) Fang-Zhu Wan et al. Journal of Translational Medicine
- Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1
- (2020) Xiaohong Hong et al. Molecular Cancer
- Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma
- (2020) Chen Chen et al. Cancer Medicine
- A novel Epstein‐Barr virus subtype associated with nasopharyngeal carcinoma found in South China
- (2020) Lawrence S. Young Cancer Communications
- ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma
- (2020) Qianping Chen et al. Frontiers in Cell and Developmental Biology
- Lgr5 maintains stemness and regulates cell property in nasopharyngeal carcinoma through Wnt/β-catenin signaling pathway
- (2020) Fangqi Li et al. Stem Cell Research
- Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
- (2020) Chuan-xia Zhang et al. Oncogenesis
- Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21
- (2020) Cheng Wu et al. Molecular Therapy-Oncolytics
- Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen
- (2020) Mengping Zhang et al. Frontiers in Oncology
- 912MO A single-arm, open-label, multicenter phase II study of camrelizumab in patients with recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC) who had progressed on ≥2 lines of chemotherapy: CAPTAIN study
- (2020) L. Zhang et al. ANNALS OF ONCOLOGY
- Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis
- (2020) Yuanji Xu et al. Cancer Cell International
- Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma
- (2020) Shanzhao Jin et al. CELL RESEARCH
- LINC00669 insulates the JAK/STAT suppressor SOCS1 to promote nasopharyngeal cancer cell proliferation and invasion
- (2020) Xiang Qing et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Chemoradiotherapy combined with NK cell transfer in a patient with recurrent and metastatic nasopharyngeal carcinoma inducing long-term tumor control
- (2020) Yuan-yuan Jin et al. MEDICINE
- Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) P. Bossi et al. ANNALS OF ONCOLOGY
- Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation
- (2020) Jiang Hu et al. CANCER GENE THERAPY
- Frizzled-7 is required for Wnt signaling in gastric tumors with and without Apc mutations.
- (2019) Dustin Flanagan et al. CANCER RESEARCH
- miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1
- (2019) Yunhong Tian et al. LABORATORY INVESTIGATION
- Progress in EBV Vaccines
- (2019) Dwain G. van Zyl et al. Frontiers in Oncology
- Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma
- (2019) Ya He et al. Cancer Management and Research
- X-chromosome association study reveals genetic susceptibility loci of nasopharyngeal carcinoma
- (2019) Xiao-Yu Zuo et al. Biology of Sex Differences
- PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
- (2019) Yongshuai Jiang et al. Human Vaccines & Immunotherapeutics
- Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation
- (2019) Ran-ran Ding et al. OncoTargets and Therapy
- Management of recurrent nasopharyngeal carcinoma: current perspectives
- (2019) F Perri et al. OncoTargets and Therapy
- Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy
- (2019) Quynh Thu Le et al. JNCI-Journal of the National Cancer Institute
- A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma
- (2019) Geok Wee Tan et al. INTERNATIONAL JOURNAL OF CANCER
- Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance
- (2019) Pei-Ying Jin et al. Cancer Cell International
- Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
- (2019) Wei Bu et al. IMMUNITY
- A Phase I/II Open‐Label Study of Nivolumab in Previously Treated Advanced or Recurrent Nasopharyngeal Carcinoma and Other Solid Tumors
- (2019) Yuxiang Ma et al. ONCOLOGIST
- Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma
- (2019) Ting Jin et al. Translational Oncology
- MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388)
- (2019) Arushi Khurana et al. OncoTargets and Therapy
- VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma
- (2019) Zixi Liang et al. Cell Death & Disease
- Epigenetics in cancer therapy and nanomedicine
- (2019) Annalisa Roberti et al. Clinical Epigenetics
- Improved Radiotherapy Sensitivity of Nasopharyngeal Carcinoma Cells by miR-29-3p Targeting COL1A1 3’-UTR
- (2019) Ying Guo et al. MEDICAL SCIENCE MONITOR
- Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma
- (2019) F. Dionisi et al. ACTA ONCOLOGICA
- Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development
- (2019) Yunyi Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma
- (2019) Min Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma
- (2019) Xiaoqin Fan et al. CANCER BIOLOGY & THERAPY
- FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway
- (2019) Min Luo et al. CANCER LETTERS
- Long non-coding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3
- (2019) Zi-Qi Zheng et al. CANCER RESEARCH
- International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma
- (2019) Anne W. Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells
- (2019) Merrin Man Long Leong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The natural flavonoid glycoside vitexin displays preclinical antitumor activity by suppressing NF-κB signaling in nasopharyngeal carcinoma
- (2019) Wenbin Wang et al. OncoTargets and Therapy
- Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials
- (2019) Jia-Wei Lv et al. Journal for ImmunoTherapy of Cancer
- Increasing incidence of Epstein‐Barr virus‐related nasopharyngeal carcinoma in the United States
- (2019) Ilona Argirion et al. CANCER
- Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma
- (2019) Rui You et al. CANCER RESEARCH
- Proton Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma: Early Clinical Outcomes From a Single Institution
- (2019) V.M. Williams et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma
- (2019) Chen Chen et al. MEDICINE
- Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells
- (2019) Anna Makowska et al. Translational Oncology
- Long noncoding RNA LINC00460 aggravates invasion and metastasis by targeting miR-30a-3p/Rap1A in nasopharyngeal carcinoma
- (2019) Xiaodong Hu et al. Human Cell
- NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition
- (2019) Wei Zhang et al. PLoS Genetics
- Long noncoding RNA DRAIC acts as a microRNA-122 sponge to facilitate nasopharyngeal carcinoma cell proliferation, migration and invasion via regulating SATB1
- (2019) Bing Liao et al. Artificial Cells Nanomedicine and Biotechnology
- LMP1‐positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling
- (2019) Zhibao Zhang et al. Cancer Medicine
- Targeting Exosomal EBV-LMP1 Transfer and miR-203 Expression via the NF-κB Pathway: The Therapeutic Role of Aspirin in NPC
- (2019) Lielian Zuo et al. Molecular Therapy-Nucleic Acids
- Comparative Safety of PD-1/PD-L1 Inhibitors for Cancer Patients: Systematic Review and Network Meta-Analysis
- (2019) Ya-fang Huang et al. Frontiers in Oncology
- IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway
- (2019) Li Gao et al. CANCER LETTERS
- Long Noncoding RNA UCA1 Accelerates Nasopharyngeal Carcinoma Cell Progression By Modulating miR-124-3p/ITGB1 Axis
- (2019) Chunxiu Liu et al. OncoTargets and Therapy
- Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
- (2019) Annika De Sousa Linhares et al. Scientific Reports
- Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
- (2019) You-Ping Liu et al. Cancer Communications
- Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma
- (2019) Ricard Mesia et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-432 Suppresses Invasion and Migration via E2F3 in Nasopharyngeal Carcinoma
- (2019) Tingting Wang et al. OncoTargets and Therapy
- Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
- (2019) Xinmao Song et al. Archives of Medical Science
- TGF-β regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma
- (2018) Mingyu Du et al. BIOMEDICINE & PHARMACOTHERAPY
- Sulforaphane promotes apoptosis, and inhibits proliferation and self-renewal of nasopharyngeal cancer cells by targeting STAT signal through miRNA-124-3p
- (2018) Xiqing Li et al. BIOMEDICINE & PHARMACOTHERAPY
- LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway
- (2018) Fei Liu et al. CANCER BIOLOGY & THERAPY
- Targetedregulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1
- (2018) Jie Gao et al. Cancer Biomarkers
- LZTS2 inhibits PI3K/AKT activation and radioresistance in nasopharyngeal carcinoma by interacting with p85
- (2018) Shuangbing Xu et al. CANCER LETTERS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
- (2018) Edwin P. Hui et al. CLINICAL CANCER RESEARCH
- Phase I Study of CC-486 Alone and in Combination With Carboplatin or nab‑paclitaxel in Patients With Relapsed or Refractory Solid Tumors
- (2018) Daniel D. Von Hoff et al. CLINICAL CANCER RESEARCH
- A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma
- (2018) Eduardo Méndez et al. CLINICAL CANCER RESEARCH
- Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma
- (2018) Juan Lu et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer
- (2018) Guanman Li et al. International Journal of Biological Sciences
- miR-150 contributes to the radioresistance in nasopharyngeal carcinoma cells by targeting glycogen synthase kinase-3β
- (2018) Yuanjian Huang et al. Journal of Cancer Research and Therapeutics
- Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
- (2018) Mei Yi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
- (2018) Brigette B.Y. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma
- (2018) Juan Lu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Activation of SREBP1-mediated lipogenesis by the Epstein-Barr Virus-encoded LMP1 promotes cell proliferation and progression of nasopharyngeal carcinoma
- (2018) Angela Kwok-Fung Lo et al. JOURNAL OF PATHOLOGY
- Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
- (2018) Voon Yee-Lin et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Ovatodiolide suppresses nasopharyngeal cancer by targeting stem cell-like population, inducing apoptosis, inhibiting EMT and dysregulating JAK/STAT signaling pathway
- (2018) Shao-Cheng Liu et al. PHYTOMEDICINE
- Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
- (2018) W. K. Jacky Lam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma
- (2018) Xiangjian Luo et al. Cell Death & Disease
- HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma
- (2018) Shiwei He et al. Cell Death & Disease
- Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway
- (2018) Meng-He Wang et al. Cell Death & Disease
- Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma
- (2018) Yi He et al. Cell Death & Disease
- Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas
- (2018) Lili Li et al. Theranostics
- Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis
- (2018) Li-Rong Wu et al. Journal of Cancer
- Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma
- (2018) Tingdong Li et al. Cancer Medicine
- The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling
- (2018) Mhairi Morris et al. Cancers
- The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
- (2018) Quan Li You et al. Cancer Biology & Medicine
- Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma
- (2018) Jin-Zhang Cheng et al. Cancer Cell International
- Abstract 4703: The inhibitor of apoptosis protein (IAP) antagonist Debio 1143 enhances the immune response to anti-PD1/L1 inhibitors in vitro and in vivo
- (2018) Antoine Attinger et al. CANCER RESEARCH
- Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein–Barr virus by whole-genome sequencing
- (2018) Chaofeng Tu et al. CARCINOGENESIS
- Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
- (2018) Cheng-Lung Hsu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Epstein-Barr Virus miR-BART5-3p inhibits p53 expression
- (2018) Xiang Zheng et al. JOURNAL OF VIROLOGY
- Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
- (2018) Wenfeng Fang et al. LANCET ONCOLOGY
- P57 -mediated autophagy promotes the efficacy of EGFR inhibitors in hepatocellular carcinoma
- (2018) Wen-Yuan Li et al. LIVER INTERNATIONAL
- Dinitrosopiperazine-decreased PKP3 through upregulating miR-149 participates in nasopharyngeal carcinoma metastasis
- (2018) Yuejin Li et al. MOLECULAR CARCINOGENESIS
- Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth
- (2018) Franck Gallardo et al. Drug Design Development and Therapy
- A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors
- (2018) Jordi Rodon et al. Oncotarget
- TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
- (2018) Jiangxia Fan et al. Clinical Epigenetics
- HLA common and well-documented alleles in China
- (2018) Y. He et al. HLA
- “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
- (2018) Emira Bousoik et al. Frontiers in Oncology
- EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma
- (2018) Yingqin Li et al. CELL DEATH AND DIFFERENTIATION
- Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
- (2018) Ning Wei et al. ONCOGENE
- Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145
- (2018) Jing Wu et al. OncoTargets and Therapy
- SIRT6 overexpression induces apoptosis of nasopharyngeal carcinoma by inhibiting NF-κB signaling
- (2018) Lei Ouyang et al. OncoTargets and Therapy
- LncRNA ANCR promotes proliferation and radiation resistance of nasopharyngeal carcinoma by inhibiting PTEN expression
- (2018) Xingkai Ma et al. OncoTargets and Therapy
- Vasculogenic mimicry formation in EBV-associated epithelial malignancies
- (2018) Tong Xiang et al. Nature Communications
- MAP2K6 is associated with radiation resistance and adverse prognosis for locally advanced nasopharyngeal carcinoma patients
- (2018) Zhanzhan Li et al. Cancer Management and Research
- Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
- (2017) Su-Mei Cao et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
- (2017) Lei Chen et al. EUROPEAN JOURNAL OF CANCER
- Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis
- (2017) Yiat Horng Leong et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience
- (2017) Juan Liu et al. International Journal of Clinical Oncology
- miR-150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma
- (2017) Xiangyong Li et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma
- (2017) Marc L Ooft et al. JOURNAL OF CLINICAL PATHOLOGY
- RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma
- (2017) Weilin Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- EBV MicroRNA BART16 Suppresses Type I IFN Signaling
- (2017) Marjolein J. G. Hooykaas et al. JOURNAL OF IMMUNOLOGY
- Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
- (2017) Yuanjun Lu et al. Journal of Innate Immunity
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
- (2017) Li Zhang et al. MOLECULAR CANCER RESEARCH
- MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway
- (2017) Li-Na Li et al. MOLECULAR CANCER THERAPEUTICS
- Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
- (2017) K.C. Allen Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
- (2017) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4
- (2017) Chengyi Jiang et al. ONCOLOGY REPORTS
- Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer
- (2017) Oscar Siu Hong Chan et al. ORAL ONCOLOGY
- Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma
- (2017) Marc L. Ooft et al. ORAL ONCOLOGY
- Epstein–Barr virus infection and nasopharyngeal carcinoma
- (2017) Sai Wah Tsao et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Nasopharyngeal carcinoma super-enhancer–driven ETV6 correlates with prognosis
- (2017) Liangru Ke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4
- (2017) Haili Hu et al. OncoTargets and Therapy
- Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-κB pathway
- (2017) Nan Cheng et al. OncoTargets and Therapy
- The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance
- (2017) Han-qun Zhang et al. OncoTargets and Therapy
- Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma
- (2017) Jianfeng Huang et al. OncoTargets and Therapy
- Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells
- (2017) Shaoyan Feng et al. OncoTargets and Therapy
- BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
- (2017) Chun-mei Kuang et al. Cell Death & Disease
- MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma
- (2017) Xin-Ran Tang et al. Cell Death & Disease
- In situ click chemistry generation of cyclooxygenase-2 inhibitors
- (2017) Atul Bhardwaj et al. Nature Communications
- MiR-20a-5p promotes radio-resistance by targeting NPAS2 in nasopharyngeal cancer cells
- (2017) Fangfang Zhao et al. Oncotarget
- Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma
- (2017) Yanyan Tang et al. Oncotarget
- LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma
- (2017) Ting-Ting Cai et al. PLoS Pathogens
- Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway
- (2017) Gang Xu et al. Biomed Research International
- Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells
- (2017) Qian Han et al. MEDICAL SCIENCE MONITOR
- Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes
- (2017) Qian Zhu et al. OncoImmunology
- Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma
- (2017) Meng Ye et al. EBioMedicine
- EBNA1-targeted probe for the imaging and growth inhibition of tumours associated with the Epstein–Barr virus
- (2017) Lijun Jiang et al. Nature Biomedical Engineering
- Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma
- (2017) Yock Ping Chow et al. Scientific Reports
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
- (2017) Michiru Nishita et al. Scientific Reports
- Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine
- (2016) P.S. Suresh et al. BIOMEDICAL CHROMATOGRAPHY
- Global trends in incidence and mortality of nasopharyngeal carcinoma
- (2016) Ling-Ling Tang et al. CANCER LETTERS
- Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial
- (2016) Ravindra Uppaluri et al. CLINICAL CANCER RESEARCH
- Caspase-dependent cleavage regulates protein levels of Epstein-Barr virus-derived latent membrane protein 1
- (2016) Sumihito Togi et al. FEBS LETTERS
- PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
- (2016) Junzo Hamanishi et al. International Journal of Clinical Oncology
- A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors
- (2016) Lee S. Rosen et al. INVESTIGATIONAL NEW DRUGS
- TP53Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
- (2016) Ge Zhou et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Epstein-Barr viral miRNAs inhibit antiviral CD4 + T cell responses targeting IL-12 and peptide processing
- (2016) Takanobu Tagawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines
- (2016) R Simo et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling
- (2016) Stephanie N. Hurwitz et al. JOURNAL OF VIROLOGY
- Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
- (2016) Li Zhang et al. LANCET
- Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
- (2016) Ying Sun et al. LANCET ONCOLOGY
- Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma
- (2016) Wing-Po Chak et al. MOLECULAR CARCINOGENESIS
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis and sensitizes nasopharyngeal carcinoma to cisplatin
- (2016) Y Zhen et al. ONCOGENE
- Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
- (2016) Victor H. F. Lee et al. PLoS One
- Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma
- (2016) Meng Xu et al. PLoS One
- Whole-exome sequencing identifiesMST1Ras a genetic susceptibility gene in nasopharyngeal carcinoma
- (2016) Wei Dai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma
- (2016) Hong Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells
- (2016) Manuel Albanese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350
- (2016) Xinle Cui et al. VACCINE
- Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma
- (2016) Minhua Wu et al. OncoTargets and Therapy
- Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene
- (2016) Hong Peng et al. Oncotarget
- Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis
- (2016) Zhi-gang Liu et al. Oncotarget
- COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
- (2016) Kowthar Y. Salim et al. Oncotarget
- PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival
- (2016) Meng-Yao Wang et al. Oncotarget
- Endoscopic nasopharyngectomy in recurrent nasopharyngeal carcinoma: a case series, literature review, and pooled analysis
- (2016) Alexander C. Vlantis et al. International Forum of Allergy & Rhinology
- MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21
- (2016) Chun Chen et al. Cancer Medicine
- Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1
- (2016) Lei Shi et al. FEBS Open Bio
- Clinical utility of plasma Epstein-Barr virus DNA andERCC1single nucleotide polymorphism in nasopharyngeal carcinoma
- (2015) Edwin P. Hui et al. CANCER
- A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
- (2015) C. X. Ma et al. CLINICAL CANCER RESEARCH
- Significance of NF-κB activation in immortalization of nasopharyngeal epithelial cells
- (2015) Dan Dan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
- (2015) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- High-Sensitivity C-Reactive Protein Complements Plasma Epstein-Barr Virus Deoxyribonucleic Acid Prognostication in Nasopharyngeal Carcinoma: A Large-Scale Retrospective and Prospective Cohort Study
- (2015) Lin-Quan Tang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)
- (2015) B. B. Y. Ma et al. INVESTIGATIONAL NEW DRUGS
- Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
- (2015) Anne W.M. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Nasopharyngeal Cancer: Molecular Landscape
- (2015) Jeff P. Bruce et al. JOURNAL OF CLINICAL ONCOLOGY
- Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
- (2015) Lin-Quan Tang et al. JNCI-Journal of the National Cancer Institute
- A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
- (2015) Javier Ogembo et al. Journal of Translational Medicine
- DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF-κB pathway
- (2015) Wei Huang et al. MEDICAL ONCOLOGY
- Has-miR-125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53-dependent manner by targeting p53 mRNA
- (2015) JIAN JUN CHEN et al. Molecular Medicine Reports
- miR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1
- (2015) QUANQUAN SUN et al. Molecular Medicine Reports
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity
- (2015) YEE-LIN VOON et al. ONCOLOGY REPORTS
- The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma
- (2015) Oscar Matzinger et al. RADIOTHERAPY AND ONCOLOGY
- The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma
- (2015) Chuan Jin et al. TUMOR BIOLOGY
- CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer
- (2015) Michael Bordonaro WORLD JOURNAL OF GASTROENTEROLOGY
- Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes
- (2015) Lili Li et al. Epigenomics
- miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma
- (2015) Luqing Zhao et al. Oncotarget
- Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling
- (2015) Qiu-Yan He et al. Oncotarget
- The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma
- (2015) Ying Guan et al. Oncotarget
- EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma
- (2015) Lifang Yang et al. Oncotarget
- miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways
- (2015) Qingmei He et al. Oncotarget
- Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
- (2015) Jie Liu et al. Scientific Reports
- Andrographolide Suppresses Proliferation of Nasopharyngeal Carcinoma Cells via Attenuating NF-κB Pathway
- (2015) Tao Peng et al. Biomed Research International
- Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
- (2015) Lin-Quan Tang et al. JNCI-Journal of the National Cancer Institute
- MiR-185-3p and miR-324-3p Predict Radiosensitivity of Nasopharyngeal Carcinoma and Modulate Cancer Cell Growth and Apoptosis by Targeting SMAD7
- (2015) Jianhua Xu et al. MEDICAL SCIENCE MONITOR
- Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma
- (2015) Wei Dai et al. Cancer Medicine
- Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening
- (2015) Yufeng Chen et al. PLoS One
- EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
- (2015) Wenfeng Fang et al. Oncotarget
- Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin
- (2015) King Chi Chan et al. Scientific Reports
- Outcome of Patients Undergoing Salvage Surgery for Recurrent Nasopharyngeal Carcinoma: A Meta-analysis
- (2014) Shorook Na’ara et al. ANNALS OF SURGICAL ONCOLOGY
- MET inhibitor PHA-665752 suppresses the hepatocyte growth factor-induced cell proliferation and radioresistance in nasopharyngeal carcinoma cells
- (2014) Tongxin Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas
- (2014) Wei-Hua Liao et al. BMC CANCER
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
- (2014) G. S. Taylor et al. CLINICAL CANCER RESEARCH
- Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
- (2014) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- HLA-ASNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese
- (2014) Yoon-Ming Chin et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells
- (2014) Dhafer Mrizak et al. JNCI-Journal of the National Cancer Institute
- Epstein-Barr Virus-Encoded Latent Membrane Protein 2A Promotes the Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma via Metastatic Tumor Antigen 1 and Mechanistic Target of Rapamycin Signaling Induction
- (2014) Z. Lin et al. JOURNAL OF VIROLOGY
- Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma
- (2014) T. Liu et al. MOLECULAR CANCER THERAPEUTICS
- The genomic landscape of nasopharyngeal carcinoma
- (2014) De-Chen Lin et al. NATURE GENETICS
- The clinical development of MEK inhibitors
- (2014) Yujie Zhao et al. Nature Reviews Clinical Oncology
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes
- (2014) M Aga et al. ONCOGENE
- Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts
- (2014) Mélanie Gressette et al. PLoS One
- 5-Azacytidine Enhances the Radiosensitivity of CNE2 and SUNE1 Cells In Vitro and In Vivo Possibly by Altering DNA Methylation
- (2014) Wei Jiang et al. PLoS One
- Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
- (2014) Bin Li et al. PLoS One
- (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial–mesenchymal transition via NF-κB p65 inactivation
- (2014) Ya-Jun Li et al. TUMOR BIOLOGY
- STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma
- (2014) Qu Zhang et al. TUMOR BIOLOGY
- TP53-induced glycolysis and apoptosis regulator promotes proliferation and invasiveness of nasopharyngeal carcinoma cells
- (2014) ELAINE YUE LING WONG et al. Oncology Letters
- Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity
- (2013) Lifang Yang et al. CANCER BIOLOGY & THERAPY
- Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
- (2013) E. P. Hui et al. CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells
- (2013) XIAOQIAN MA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
- (2013) Qingjie Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma
- (2013) Grace Tin-Yun Chung et al. JOURNAL OF PATHOLOGY
- Therapeutic Evaluation of Epstein-Barr Virus-encoded Latent Membrane Protein-1 Targeted DNAzyme for Treating of Nasopharyngeal Carcinomas
- (2013) Ya Cao et al. MOLECULAR THERAPY
- Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
- (2013) Whay-Kuang Chia et al. MOLECULAR THERAPY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
- (2013) Yunbao Pan et al. PLoS One
- Epstein-Barr Virus_Encoded LMP1 Upregulates MicroRNA-21 to Promote the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin-Induced Apoptosis by Suppressing PDCD4 and Fas-L
- (2013) Guang-Da Yang et al. PLoS One
- GWAS of 126,559 Individuals Identifies Genetic Variants Associated with Educational Attainment
- (2013) C. A. Rietveld et al. SCIENCE
- A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice
- (2012) J. Waaler et al. CANCER RESEARCH
- Effective Treatment of Metastatic Forms of Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
- (2012) C. Smith et al. CANCER RESEARCH
- Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma
- (2012) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma
- (2012) Ying Jin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Epstein-Barr Virus Latent Membrane Protein 1 Regulates the Function of Interferon Regulatory Factor 7 by Inducing Its Sumoylation
- (2012) G. L. Bentz et al. JOURNAL OF VIROLOGY
- Epigenetic Histone Modification of Epstein-Barr Virus BZLF1 Promoter during Latency and Reactivation in Raji Cells
- (2012) T. Murata et al. JOURNAL OF VIROLOGY
- Evaluation of Human Leukocyte Antigen-A (HLA-A), Other Non-HLA Markers on Chromosome 6p21 and Risk of Nasopharyngeal Carcinoma
- (2012) Wan-Lun Hsu et al. PLoS One
- Host–tumor interactions in nasopharyngeal carcinomas
- (2012) Claire Gourzones et al. SEMINARS IN CANCER BIOLOGY
- Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches
- (2012) Kwok-Wai Lo et al. SEMINARS IN CANCER BIOLOGY
- The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
- (2012) Christopher W. Dawson et al. SEMINARS IN CANCER BIOLOGY
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
- A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
- (2011) W. K. Chia et al. ANNALS OF ONCOLOGY
- Modern treatment for nasopharyngeal carcinoma: current status and prospects
- (2011) Sylvie Rottey et al. CURRENT OPINION IN ONCOLOGY
- Detection of Epstein-Barr Virus DNA in Serum or Plasma for Nasopharyngeal Cancer: A Meta-Analysis
- (2011) Yu Liu et al. Genetic Testing and Molecular Biomarkers
- EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma
- (2011) Zijian Li et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response
- (2011) Qianjin Liao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
- (2011) R. Ruiss et al. JOURNAL OF VIROLOGY
- A Human Fab-Based Immunoconjugate Specific for the LMP1 Extracellular Domain Inhibits Nasopharyngeal Carcinoma Growth In Vitro and In Vivo
- (2011) R. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2011) Mu-Yan Cai et al. MOLECULAR MEDICINE
- A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
- (2011) Lifang Yang et al. MOLECULES
- An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway
- (2011) F. C. Gonsalves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling
- (2010) Zhenlian Wang et al. EUROPEAN JOURNAL OF CANCER
- Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
- (2010) Cliona Grant et al. Expert Review of Anticancer Therapy
- Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma
- (2010) King Chi Chan et al. INTERNATIONAL JOURNAL OF CANCER
- Physical and Functional HAT/HDAC Interplay Regulates Protein Acetylation Balance
- (2010) Alessia Peserico et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo
- (2010) Hanguo Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
- (2010) Chrystal U. Louis et al. JOURNAL OF IMMUNOTHERAPY
- EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model
- (2010) Xia Ke et al. MEDICAL ONCOLOGY
- Primary Nasopharyngeal Carcinoma: Diagnostic Accuracy of MR Imaging versus that of Endoscopy and Endoscopic Biopsy
- (2010) Ann D. King et al. RADIOLOGY
- Modulation of innate immunity system by EpsteinâBarr virus-encoded non-coding RNA and oncogenesis
- (2009) Mrinal Samanta et al. CANCER SCIENCE
- Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells
- (2009) Daphna Nachmani et al. Cell Host & Microbe
- Targeting the PI3K signaling pathway in cancer
- (2009) Kwok-Kin Wong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review
- (2009) W M Yu et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation
- (2009) K M Shah et al. ONCOGENE
- A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
- (2009) Lesley Rees et al. TRANSPLANTATION
- Functional Analysis of a Cell Cycle-Associated, Tumor-Suppressive Gene, Protein Tyrosine Phosphatase Receptor Type G, in Nasopharyngeal Carcinoma
- (2008) A. K. L. Cheung et al. CANCER RESEARCH
- Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesis
- (2008) Josephine Chou et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells
- (2008) Xuechi Lin et al. INTERNATIONAL JOURNAL OF CANCER
- Epstein-Barr Virus Latent Membrane Protein 1 Represses DNA Repair through the PI3K/Akt/FOXO3a Pathway in Human Epithelial Cells
- (2008) Y.-R. Chen et al. JOURNAL OF VIROLOGY
- Epstein–Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling
- (2008) M Samanta et al. ONCOGENE
- Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease
- (2008) Hiroshi Kimura et al. REVIEWS IN MEDICAL VIROLOGY
- Multiple roles of LMP1 in Epstein-Barr virus induced immune escape
- (2008) J.M. Middeldorp et al. SEMINARS IN CANCER BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation